Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy

Andreas Kronbichler, Jun Oh, Björn Meijers, Gert Mayer, Jae Il Shin

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Primary membranous nephropathy (MN) is the leading cause of nephrotic syndrome in adults. Discovery of several antibodies has contributed to an increased understanding of MN. Antibodies against the M-type phospholipase A2 receptor (PLA2R) are present in 50-100% with primary MN and are associated with a lower frequency of spontaneous remission. High levels are linked with a higher probability of treatment resistance, higher proteinuria, and impaired renal function, as well as a more rapid decline of kidney function during follow-up. Immunologic remission precedes reduction of proteinuria by months. Pretransplant evaluation of PLA2R antibodies is warranted to predict recurrence of disease following renal transplantation. Several risk alleles related to the PLA2R1 gene and within the HLA loci have been identified, whereas epitope spreading of PLA2R may predict treatment response. More recently, thrombospondin type 1 domain-containing 7A (THSD7A) antibodies have been discovered in primary MN. Several other rare antigens have been described, including antibodies against neutral endopeptidase as a cause of antenatal MN and circulating cationic bovine serum albumin as an antigen with implications in childhood MN. This review focuses on the progress with a special focus on diagnostic accuracy, predictive value, and treatment implications of the established and proposed antigens.

Original languageEnglish
Article number1936372
JournalBioMed Research International
Volume2017
DOIs
Publication statusPublished - 2017 Jan 1

Fingerprint

Membranous Glomerulonephritis
Phospholipase A2 Receptors
Antibodies
Antigens
Proteinuria
Thrombospondin 1
Neprilysin
Spontaneous Remission
Kidney
Bovine Serum Albumin
Nephrotic Syndrome
Epitopes
Kidney Transplantation
Genes
Therapeutics
Alleles
Recurrence

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)

Cite this

Kronbichler, Andreas ; Oh, Jun ; Meijers, Björn ; Mayer, Gert ; Shin, Jae Il. / Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy. In: BioMed Research International. 2017 ; Vol. 2017.
@article{807ae83a13014f9a945f65f53b6f1803,
title = "Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy",
abstract = "Primary membranous nephropathy (MN) is the leading cause of nephrotic syndrome in adults. Discovery of several antibodies has contributed to an increased understanding of MN. Antibodies against the M-type phospholipase A2 receptor (PLA2R) are present in 50-100{\%} with primary MN and are associated with a lower frequency of spontaneous remission. High levels are linked with a higher probability of treatment resistance, higher proteinuria, and impaired renal function, as well as a more rapid decline of kidney function during follow-up. Immunologic remission precedes reduction of proteinuria by months. Pretransplant evaluation of PLA2R antibodies is warranted to predict recurrence of disease following renal transplantation. Several risk alleles related to the PLA2R1 gene and within the HLA loci have been identified, whereas epitope spreading of PLA2R may predict treatment response. More recently, thrombospondin type 1 domain-containing 7A (THSD7A) antibodies have been discovered in primary MN. Several other rare antigens have been described, including antibodies against neutral endopeptidase as a cause of antenatal MN and circulating cationic bovine serum albumin as an antigen with implications in childhood MN. This review focuses on the progress with a special focus on diagnostic accuracy, predictive value, and treatment implications of the established and proposed antigens.",
author = "Andreas Kronbichler and Jun Oh and Bj{\"o}rn Meijers and Gert Mayer and Shin, {Jae Il}",
year = "2017",
month = "1",
day = "1",
doi = "10.1155/2017/1936372",
language = "English",
volume = "2017",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy. / Kronbichler, Andreas; Oh, Jun; Meijers, Björn; Mayer, Gert; Shin, Jae Il.

In: BioMed Research International, Vol. 2017, 1936372, 01.01.2017.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy

AU - Kronbichler, Andreas

AU - Oh, Jun

AU - Meijers, Björn

AU - Mayer, Gert

AU - Shin, Jae Il

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Primary membranous nephropathy (MN) is the leading cause of nephrotic syndrome in adults. Discovery of several antibodies has contributed to an increased understanding of MN. Antibodies against the M-type phospholipase A2 receptor (PLA2R) are present in 50-100% with primary MN and are associated with a lower frequency of spontaneous remission. High levels are linked with a higher probability of treatment resistance, higher proteinuria, and impaired renal function, as well as a more rapid decline of kidney function during follow-up. Immunologic remission precedes reduction of proteinuria by months. Pretransplant evaluation of PLA2R antibodies is warranted to predict recurrence of disease following renal transplantation. Several risk alleles related to the PLA2R1 gene and within the HLA loci have been identified, whereas epitope spreading of PLA2R may predict treatment response. More recently, thrombospondin type 1 domain-containing 7A (THSD7A) antibodies have been discovered in primary MN. Several other rare antigens have been described, including antibodies against neutral endopeptidase as a cause of antenatal MN and circulating cationic bovine serum albumin as an antigen with implications in childhood MN. This review focuses on the progress with a special focus on diagnostic accuracy, predictive value, and treatment implications of the established and proposed antigens.

AB - Primary membranous nephropathy (MN) is the leading cause of nephrotic syndrome in adults. Discovery of several antibodies has contributed to an increased understanding of MN. Antibodies against the M-type phospholipase A2 receptor (PLA2R) are present in 50-100% with primary MN and are associated with a lower frequency of spontaneous remission. High levels are linked with a higher probability of treatment resistance, higher proteinuria, and impaired renal function, as well as a more rapid decline of kidney function during follow-up. Immunologic remission precedes reduction of proteinuria by months. Pretransplant evaluation of PLA2R antibodies is warranted to predict recurrence of disease following renal transplantation. Several risk alleles related to the PLA2R1 gene and within the HLA loci have been identified, whereas epitope spreading of PLA2R may predict treatment response. More recently, thrombospondin type 1 domain-containing 7A (THSD7A) antibodies have been discovered in primary MN. Several other rare antigens have been described, including antibodies against neutral endopeptidase as a cause of antenatal MN and circulating cationic bovine serum albumin as an antigen with implications in childhood MN. This review focuses on the progress with a special focus on diagnostic accuracy, predictive value, and treatment implications of the established and proposed antigens.

UR - http://www.scopus.com/inward/record.url?scp=85028671952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028671952&partnerID=8YFLogxK

U2 - 10.1155/2017/1936372

DO - 10.1155/2017/1936372

M3 - Review article

C2 - 28904948

AN - SCOPUS:85028671952

VL - 2017

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 1936372

ER -